Adult-onset idiopathic nephrotic syndrome associated with pure diffuse mesangial hypercellularity

Nephrology Dialysis Transplantation

Volumn 15, Issue 7, 2000, Pages 981-987

  Alexopoulos, Efstathios ^a   Papagianni, Aikaterini ^a   Stangou, Maria ^a   Pantzaki, Aphroditi ^a   Papadimitriou, Menelaos ^a  

^a Aristotle University of Thessaloniki   (Greece)

Author keywords

Diffuse mesangial hypercellularity; IgM nephropathy; Nephrotic syndrome; Outcome; Prognosis; Treatment

Indexed keywords

CYCLOSPORIN; IMMUNOGLOBULIN M; PREDNISOLONE;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; KIDNEY FAILURE; KIDNEY FIBROSIS; KIDNEY FUNCTION; MALE; MESANGIUM CELL; MULTIVARIATE ANALYSIS; NEPHROTIC SYNDROME; ONSET AGE; PRIORITY JOURNAL; PROGNOSIS; REMISSION; RETROSPECTIVE STUDY; SCLEROSIS;

EID: 0034087857     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/15.7.981     Document Type: Article

References (33)

1. Churg J, Habib R, White RHR. Pathology of the nephrotic syndrome in children: a report of the International Study of Kidney Disease in Children. Lancet 1970; 1: 1299-1302
2. White RHR, Glasgow EF, Mills RJ. Clinicopathological study of nephrotic syndrome in childhood. Lancet 1970; 1: 1353-1359
3. Cohen AH, Adler SG. Mesangial proliferative glomerulonephritis. In: Massry SG, Glassock RJ, eds. Textbook of Nephrology 3rd edn, Vol. 1. Williams & Wilkins, Baltimore, 1995; 739-742
4. Brown EA, Upadhyaya K, Hayslett JP, Kashgarian M, Siegel NJ. The clinical course of mesangial proliferative glomerulonephritis. Medicine 1979; 58: 295-303
5. International Study of Kidney Disease in Children. Primary nephrotic syndrome in children: clinical significance of histopathologic variants of minimal change and of diffuse mesangial hypercellularity. Kidney Int 1981; 20: 765-771
6. Habib R, Churg J, Bernstein J et al. Minimal change disease, mesangial proliferative glomerulonephritis and focal sclerosis: individual entities or a spectrum of disease? In: Robinson RR, ed. Nephralogy. Springer Verlag, New York, 1984; 634-644
7. Waldherr R, Gubler ME, Levy M, Broyer M, Habib R. The significance of pure diffuse mesangial proliferation in idiopathic nephrotic syndrome. Clin Nephrol 1978; 10: 171-179
8. Hirszel P, Yamase HT, Carney WR, et al. Mesangial proliferative glomerulonephritis with IgM deposits. Clinicopathologic analysis and evidence for morphologic transitions. Nephron 1984; 38: 100-108
9. D'Agati V. The many masks of focal segmental glomerulosclerosis. Kidney Int 1994; 46: 1223-1241
10. Border WA. Distinguishing minimal-change disease from mesangial disorders. Kidney Int 1988; 34: 419-434
11. Chen YP, Wang HY, Zou WZ. Non-IgA mesangial proliferate glomerulonephritis. Clinical and pathological analysis of 77 cases. Clin Med J 1989; 102: 510-515
12. Andal A, Saxena S, Chellani HK, Sharma S. Pure mesangial proliferative glomerulonephritis. A clinicomorphologic analysis and its possible role in morphologic transition of minimal change lesion. Nephron 1989; 51: 314-319
13. Cohen AH, Border WA, Glassock RJ. Nephrotic syndrome with glomerular mesangial IgM deposits. Lab Invest 1978; 38: 610-619
14. Tejani A, Nicastri AD. Mesangial IgM nephropathy. Nephron 1983; 35: 1-5
15. Allen WR, Travis LB, Cavallo T, Brouhard BH, Cunningham RJ. Immune deposits and mesangial hypercellularity in minimal change nephrotic syndrome: clinical relevance. J Pediatr 1982; 100: 188-191
16. Cohen AH, Border WA. Mesangial proliferative glomerulonephritis. Semin Nephrol 1982; 2: 228-240
17. Kipolovic J, Shvil Y, Pomeranz A, Ron N, Rubinger D, Oren R. IgM nephropathy: morphological study related to clinical findings. Am J Nephrol 1987; 7: 275-280
18. Gavallo T, Johnson MP. Immunopathologic study of minimal-change glomerular disease with mesangial IgM deposits. Nephron 1981; 2: 281-284
19. Yang JY, Melvin T, Sibley R, Michael AF. No evidence for a specific role of IgM in mesangial proliferation of idiopathic nephrotic syndrome. Kidney Int 1984; 25: 100-106
20. Vilches AR, Turner DR, Cameron JS, Ogg CS, Chantler C, Williams DG. Significance of mesangial IgM deposition in 'minimal change' nephrotic syndrome. Lab Invest 1982; 46: 10-15
21. Habib R, Girardin E, Gagnadoux MF, Hinglais N, Levy M, Broyer M. Immunopathological findings in idiopathic nephrosis: clinical significance of glomerular 'immune deposits'. Pediat Nephrol 1988; 2: 402-408
22. Hsu HC, Chen WY, Lin GJ, Kao SL, Huang CC, Lin CY. Clinical and immunopathologic study of mesangial IgM nephropathy: Report of 41 cases. Histopathology 1984; 8: 435-466
23. Churg J, Sobin LH. Renal disease. Classification and atlas of glomerular diseases. Igaku-Shoin Tokyo, 1982; 67-82, 127-165
24. Nadasdy T, Silva FG, Hogg RJ. Minimal change nephrotic syndrome focal sclerosis complex (including IgM nephropathy and diffuse mesangial hypercellularity). In: Tisher CC, Brenner BM, eds. Renal Pathology. With Clinical and Functional Correlations. J.B. Lippincott Company, Philadelphia, 1994; 330-389
25. Coggins CH and the Collaborative Study. Adult minimal change nephropathy: experience of the Collaborative Study of Glomerular Disease. Trans Am Clin Climatol Assoc 1985; 97: 18-26
26. Nolasco F, Cameron JS, Heywood EF, Hicks J, Ogg C, Williams DG. Adult-onset minimal change nephrotic syndrome: a long-term follow-up. Kidney Int 1986; 29: 1215-1223
27. Southwest Pediatric Nephrology Study Group. Childhood nephrotic syndrome associated with diffuse mesangial hypercellularity. Kidney Int 1983; 24: 87-94
28. Alexopoulos E, Stangou M, Papagianni A, Pantzaki A, Papadimitriou M. Factors influencing the course and the response to treatment in primary focal segmental glomerulosclerosis. (submitted for publication)
29. Ponticelli C, Rivolta F. Cyclosporine in nephrotic syndrome. Transplant Proc 1988; 20 [Suppl. 4]: 253-258
30. Tejani A, Gonzalez R, Rajpoot D, Sharma R, Pomrantz A. A randomized trial of cyclosporine with low-dose prednisone compared with high-dose prednisone in nephrotic syndrome. Transplant Proc 1988; 20 [Suppl. 4]: 262-264
31. Zietse R, Wenting GJ, Karmer P, Schalekamp MADH, Weimer W. Fractional excretion of protein: a marker of the efficacy of cyclosporine A treatment in nephrolic syndrome. Transplant Proc 1988; 20 [Suppl. 4]: 280-284
32. Trompeter RS, Loyd BW, Hicks J, White RHR, Cameron JS. Long-term outcome for children with minimal change nephrotic syndrome. Lancet 1985; 1: 368-370
33. Joh K., Matsuyama N, Kanetsuma Y et al. Nephrotic syndrome associated with diffuse mesangial hypercellularity: is it a heterogeneous disease entity? Am J Nephrol 1998; 18: 214-220